Scott Goodrich, MD
Gynecologic Oncology · Fort Wayne, INNPI 1083748966
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,704 of the $3,728 with a category attached, or 72.5%. 25 manufacturers reported payments, led by Caris MPI, Inc. at 30.5% of the total. 2025 is the largest year on record at $1,653, 2.9 times the $572 reported in 2019.
Across 51 payments — averaging $73.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Caris MPI, Inc.$1K
- AstraZeneca$382
- Seagen Inc.$324
- Myriad Genetic Laboratories, Inc.$218
- Intuitive Surgical$207
- Bayer$149
- plus $1K from 19 others
What the payments were for
- Consulting fees$90024%
- Food & beverage$2,70473%
- Education$1243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Caris MPI, Inc. | 3 | $1,138 |
| AstraZeneca | 7 | $382 |
| Seagen Inc. | 3 | $324 |
| Myriad Genetic Laboratories, Inc. | 2 | $218 |
| Intuitive Surgical | 2 | $207 |
| Bayer | 3 | $149 |
| AbbVie | 1 | $132 |
| Genmab U.S., Inc. | 1 | $125 |
| Aspira Women's Health Inc | 2 | $125 |
| Merck | 6 | $122 |
| Clovis Oncology, Inc. | 3 | $109 |
| Medical Device Business Services, Inc. | 1 | $104 |
| Therapeuticsmd, Inc. | 1 | $101 |
| Eisai Inc. | 2 | $94 |
| Daiichi Sankyo Inc. | 1 | $93 |
| GSK | 1 | $90 |
| Novartis | 3 | $67 |
| Bristol Myers Squibb | 2 | $33 |
| Tesaro, Inc. | 1 | $19 |
| Acrotech Biopharma Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Immunogen, Inc. | 1 | $17 |
| Genentech, Inc. | 1 | $17 |
| Adaptive Biotechnologies Corporation | 1 | $14 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MI CANCER SEEK$1,138
- TIVDAK$369
- myRisk$218
- Elahere$132
- LYNPARZA$124
- Enhertu$121
- Vitrakvi$114
- Da Vinci Surgical System$114
- VISTASEAL$104
- IMVEXXY$101
How this compares
$3,728 in reported general payments places this provider in the 70th percentile of 26 gynecologic oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 23 | $249 |
| Prochlorperazine Maleate | 15 | $143 |
| Letrozole | 15 | $136 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $131 |
| Oxycodone Hcl | 34 | $98 |
| Gabapentin | 12 | $90 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Fort Wayne
- Bogna BrzezinskaFort Wayne$3K
- Anya MenziesFort Wayne$988
- John GeislerFort Wayne$547
- Sameer SharmaDyer$27K
- Nonyem OnujioguSouth Bend$23K
- Paul LiuSouth Bend$15K
- Iwona PodzielinskiWarsaw$8K
- Jessica Parker MetterIndianapolis$6K
- Hilary HinshawIndianapolis$5K
- Lisa LandrumIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.